Company: INSP
Filing Date: 2025-05-05
Form Type: 8-K
Source: 0001609550-25-000019
Chunk: 0

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-05-05
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07.    Submission of Matters to a Vote of Security Holders.
On May 1, 2025, Inspire Medical Systems, Inc. (the “Company”) held its annual meeting of stockholders. A total of 28,727,792 shares of the Company’s common stock were represented in person or by proxy at the meeting, representing approximately 96.53% of the Company’s common stock outstanding as of the March 4, 2025 record date. The following are the voting results for the proposals considered and voted upon at the meeting, each of which were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on March 18, 2025.
Item 1 — Election of Directors
The following director nominees were elected as Class I directors to hold office until the Company’s annual meeting of stockholders to be held in 2028 and until their respective successors have been duly elected and qualified. The number of votes cast for and withheld from each nominee and the number of broker non-votes with respect to each nominee were as follows:

                                 Votes FOR       Votes WITHHELD        Broker Non-Votes
Cynthia B. Burks                20,494,838            6,413,474               1,819,480
Timothy P. Herbert              21,076,649            5,831,663               1,819,480
Shawn T McCormick               19,908,767            6,999,545               1,819,480
Item 2 — Ratification of the Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for 2022
The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025 by voting as follows:

Votes FOR         Votes AGAINST        Votes ABSTAINED         Broker Non-Votes     
28,355,000        364,346              8,446                   —                    
Item 3 — Advisory Vote on Approval of the Compensation of the Company's Named Executive Officers
The Company’s stockholders approved, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers by voting as follows:

Votes FOR         Votes AGAINST        Votes ABSTAINED         Broker Non-Votes     
25,013,834        1,861,331            33,147                  1,819,480